North Central Cancer Treatment Group N0531: Phase II trial of weekly albumin-bound paclitaxel (ABI-007; Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer

Alvaro Moreno-Aspitia, Edith A. Perez

Research output: Contribution to journalArticle

15 Scopus citations
Original languageEnglish (US)
Pages (from-to)361-364
Number of pages4
JournalClinical breast cancer
Volume6
Issue number4
DOIs
StatePublished - Oct 2005

Keywords

  • Dose modifications
  • First-line chemotherapy
  • Pharmacogenetics
  • Taxanes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this